AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
Byline: Christopher Rowland
Nov. 1--A Philadelphia securities firm has begun marketing a novel type of healthcare investment for those with a high tolerance for risk and a passion for combating particular diseases, such as diabetes and cancer.
Wellspring BioCapital Partners, led by former Philadelphia Republican mayoral candidate Sam Katz, has set up five "unit investment trusts," akin to mutual funds.
Each one contains a narrow collection of stocks in pharmaceutical and biotechnology companies that are working on or marketing treatments for Alzheimer's disease, breast and ovarian cancer, prostate cancer, diabetes, or rheumatoid arthritis.
…